0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Artesunate"

Following a topic allows Research and Markets to customize your experience and provide personalized recommendations.
From
EUR$3,545USDGBP
EUR$3,939USDGBP
From
EUR$4,150USDGBP
From
EUR$4,750USDGBP
From
EUR$4,750USDGBP
From
EUR$2,000USDGBP
From
EUR$2,500USDGBP
From
EUR$1,500USDGBP
From
EUR$1,500USDGBP
From
EUR$1,500USDGBP
From
EUR$1,500USDGBP
From
EUR$1,500USDGBP
From
EUR$1,500USDGBP
From
EUR$1,500USDGBP
From
EUR$1,500USDGBP
From
EUR$1,500USDGBP
From
EUR$1,500USDGBP
From
EUR$1,500USDGBP
Loading Indicator

Artesunate is an antimalarial drug used to treat severe malaria. It is a semi-synthetic derivative of the naturally occurring sesquiterpene lactone artemisinin, which is extracted from the plant Artemisia annua. Artesunate is used in combination with other antimalarial drugs to treat severe malaria, as it is more effective than monotherapy. It is also used to treat uncomplicated malaria, as it is more effective than other antimalarial drugs. Artesunate is available in both oral and injectable forms, and is used in combination with other antimalarial drugs to treat severe malaria. The artesunate market is a rapidly growing market, driven by the increasing prevalence of malaria and the need for effective treatments. The market is expected to grow at a steady rate in the coming years, as the demand for antimalarial drugs increases. Some of the major companies in the artesunate market include Sanofi, GlaxoSmithKline, Novartis, Pfizer, Merck, and Cipla. Show Less Read more

This website uses cookies to ensure you get the best experience. Learn more